[
    {
        "masterItemId": "NCLEX-2026-MISSION-500-34-1771960453647",
        "itemType": "dragAndDropCloze",
        "stimulus": "You are caring for Ms. Tanaka, a 72-year-old patient admitted for atrial fibrillation. She is currently on heparin and warfarin therapy. Review the EHR and answer the question.",
        "stem": "Ms. Tanaka's aPTT result is [apttResult] seconds, which is [apttTherapeutic] the therapeutic range of [apttRange]. Her INR result is [inrResult], which is [inrTherapeutic] the therapeutic range of [inrRange]. Based on these results, the nurse should anticipate [intervention].",
        "rubric": {
            "scoringType": "0/1",
            "feedback": {}
        },
        "responseOptions": [
            {
                "optionId": "apttResult_1",
                "content": "85"
            },
            {
                "optionId": "apttResult_2",
                "content": "35"
            },
            {
                "optionId": "apttResult_3",
                "content": "65"
            },
            {
                "optionId": "apttTherapeutic_1",
                "content": "below"
            },
            {
                "optionId": "apttTherapeutic_2",
                "content": "within"
            },
            {
                "optionId": "apttTherapeutic_3",
                "content": "above"
            },
            {
                "optionId": "apttRange_1",
                "content": "30-40 seconds"
            },
            {
                "optionId": "apttRange_2",
                "content": "60-80 seconds"
            },
            {
                "optionId": "apttRange_3",
                "content": "46-70 seconds"
            },
            {
                "optionId": "inrResult_1",
                "content": "1.5"
            },
            {
                "optionId": "inrResult_2",
                "content": "3.0"
            },
            {
                "optionId": "inrResult_3",
                "content": "0.9"
            },
            {
                "optionId": "inrTherapeutic_1",
                "content": "below"
            },
            {
                "optionId": "inrTherapeutic_2",
                "content": "within"
            },
            {
                "optionId": "inrTherapeutic_3",
                "content": "above"
            },
            {
                "optionId": "inrRange_1",
                "content": "0.8-1.2"
            },
            {
                "optionId": "inrRange_2",
                "content": "2.0-3.0"
            },
            {
                "optionId": "inrRange_3",
                "content": "3.0-4.0"
            },
            {
                "optionId": "intervention_1",
                "content": "increasing the heparin dose"
            },
            {
                "optionId": "intervention_2",
                "content": "decreasing the warfarin dose"
            },
            {
                "optionId": "intervention_3",
                "content": "holding the heparin and warfarin"
            }
        ],
        "correctResponse": {
            "apttResult": "65",
            "apttTherapeutic": "within",
            "apttRange": "46-70 seconds",
            "inrResult": "1.5",
            "inrTherapeutic": "below",
            "inrRange": "2.0-3.0",
            "intervention": "increasing the warfarin dose"
        },
        "rationale": {
            "correct": "The therapeutic range for aPTT during heparin therapy is typically 1.5 to 2.5 times the normal control value (approximately 46-70 seconds, depending on the lab). A value of 65 seconds indicates that the heparin is within the therapeutic range. The therapeutic INR range for warfarin is generally 2.0-3.0 for atrial fibrillation. An INR of 1.5 is below the therapeutic range, indicating that the warfarin dose needs to be increased to achieve adequate anticoagulation. Holding both medications would be inappropriate, as the patient needs anticoagulation due to atrial fibrillation.",
            "incorrect": "",
            "clinicalPearls": [
                "Close monitoring of aPTT and INR is crucial when managing patients on heparin and warfarin. Understanding the therapeutic ranges for each medication is essential for safe and effective anticoagulation. Individual patient responses can vary, necessitating frequent adjustments to dosage."
            ],
            "questionTrap": {
                "trap": "Focus Area",
                "howToOvercome": "The question traps test takers to misinterpret the lab values or the therapeutic ranges. Test takers may assume that any abnormal result means the nurse should hold the medication, overlooking the need to increase the dose to reach the therapeutic target. Also, mistaking the therapeutic range for aPTT and INR will cause the wrong dose adjustment."
            },
            "mnemonic": {
                "title": "HINT",
                "expansion": "WIT (Warfarin INR Therapeutic range 2-3); HAT (Heparin aPTT Therapeutic range 46-70)"
            },
            "answerBreakdown": [],
            "reviewUnits": []
        },
        "itemContext": {
            "SBAR": "**07:00 SBAR - Ms. Tanaka**\n\n**Situation:** Ms. Tanaka, 72-year-old female, admitted for atrial fibrillation. She is currently on heparin and warfarin.\n\n**Background:** Ms. Tanaka has a history of paroxysmal atrial fibrillation and was started on heparin and warfarin three days ago. She initially responded well to the treatment, but her INR has been fluctuating. She denies any bleeding or bruising.\n\n**Assessment:** Patient is alert and oriented. Vital signs: BP 130/80 mmHg, HR 88 bpm and irregular, RR 18, Temp 37.0째C (98.6째F), SpO2 98% on room air. Lungs clear to auscultation. No edema noted. Heart sounds irregular. Current aPTT is pending review. Current INR is pending review. No signs of bleeding or unusual bruising noted. She reports mild fatigue but no other complaints.\n\n**Recommendation:** Please review the latest aPTT and INR results and adjust the heparin and warfarin doses accordingly. Consider repeating labs later today to assess response to any changes in dosage. Monitor for any signs of bleeding. Continue to assess for atrial fibrillation control.",
            "Labs": "aPTT: 65 seconds (Therapeutic Range: 46-70 seconds on Heparin)\nINR: 1.5 (Therapeutic Range: 2.0-3.0 on Warfarin)",
            "Vitals": "BP: 130/80 mmHg\nHR: 88 bpm (irregular)\nRR: 18\nTemp: 37.0째C (98.6째F)\nSpO2: 98% on room air",
            "Radiology": "N/A",
            "MAR": "Heparin 1000 units/hour IV\nWarfarin 5mg PO daily"
        },
        "clinicalPearls": "Close monitoring of aPTT and INR is crucial when managing patients on heparin and warfarin. Understanding the therapeutic ranges for each medication is essential for safe and effective anticoagulation. Individual patient responses can vary, necessitating frequent adjustments to dosage.",
        "questionTrap": "The question traps test takers to misinterpret the lab values or the therapeutic ranges. Test takers may assume that any abnormal result means the nurse should hold the medication, overlooking the need to increase the dose to reach the therapeutic target. Also, mistaking the therapeutic range for aPTT and INR will cause the wrong dose adjustment.",
        "mnemonic": "WIT (Warfarin INR Therapeutic range 2-3); HAT (Heparin aPTT Therapeutic range 46-70)",
        "type": "dragAndDropCloze",
        "scoring": {
            "method": "polytomous",
            "maxPoints": 1
        },
        "pedagogy": {
            "bloomLevel": "apply",
            "cjmmStep": "analyzeCues",
            "nclexCategory": "Physiological Adaptation",
            "topicTags": [
                "Uncategorized"
            ],
            "difficulty": 3
        }
    }
]